MedTrace Logo

The Hemostatic Effectiveness of "HANBIO" Gauze During Non-emergent Gynecology Surgery.

NCT06715696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-29

No results posted yet for this study

Summary

The objective of this study is to collect the hemostatic effectiveness and device safety data of "HANBIO" Gauze in subjects have acute wound result from gynecology surgery.

Conditions

  • Wounds and Injuries
  • Hemostasis

Interventions

DEVICE

"HANBIO" Gauze (Sterilized, 1% Collagen)

After tissue resection in a standard procedure for gynecological surgery, direct application of "HANBIO" Gauze to cover the bleeding site/area which identified during dissection.

Sponsors & Collaborators

  • HAN Biomedical Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06715696 on ClinicalTrials.gov